ABCA4 is an N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine importer
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
ATP-binding cassette (ABC) transporters comprise a superfamily of proteins, which actively transport a variety of compounds across cell membranes. Mammalian and most eukaryotic ABC transporters function as exporters, flipping or extruding substrates from the cytoplasmic to the extracellular or lumen side of cell membranes. Prokaryotic ABC transporters function either as exporters or importers. Here we show that ABCA4, an ABC transporter found in retinal photoreceptor cells and associated with Stargardt macular degeneration, is a novel importer that actively flips N-retinylidene-phosphatidylethanolamine from the lumen to the cytoplasmic leaflet of disc membranes, thereby facilitating the removal of potentially toxic retinoid compounds from photoreceptors. ABCA4 also actively transports phosphatidylethanolamine in the same direction. Mutations known to cause Stargardt disease decrease N-retinylidene-phosphatidylethanolamine and phosphatidylethanolamine transport activity of ABCA4. These studies provide the first direct evidence for a mammalian ABC transporter that functions as an importer and provide insight into mechanisms underlying substrate transport and the molecular basis of Stargardt disease. In mammalian cells, ABC transporter proteins were thought to exclusively export a range of substrates out of cells. Quazi and colleagues show that, in retinal photoreceptor cells, ABCA4 is acting as an importer of phospholipids and that mutations known to cause Stargardt disease decrease its activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 ATP-dependent transfer of ATR from donor ABCA4 proteoliposomes to acceptor liposomes. Donor proteoliposomes consisted of DOPC, DOPE and BPL at a weight ratio of 6:2:2 reconstituted with ABCA4 purified from either (a–c) bovine ROS membranes or (d) ABCA4-transfected HEK293 cell extracts. Acceptor liposomes consisted of DOPC and DOPE at a weight ratio of 7:3. (a) Time course for the transfer of [3H] ATR from donor proteoliposomes to acceptor liposome vesicles. [3H] ATR rapidly distributed between donor proteoliposomes and acceptor liposomes with ~28% of the ATR partitioning into the acceptor liposomes at 37 °C. After 30 min, 2 mM ATP or AMP–PNP or control buffer was added (arrow) and radioactivity in the acceptor liposomes was measured at various times. Data are plotted as a mean with error bars representing±s.e.m. for n=3. Coomassie blue (CB)-stained gel and western blot (WB) shows the purity of the ABCA4 used for reconstitution. (b) ATP-dependent rate of [3H] ATR transfer as a function of ATR concentration. Solid line shows best-fit sigmoidal curve for K0.5 of 4.9±0.2 μM and a Vmax of 35.5±0.7 pmol min−1 per μg protein yielding a Hill coefficient of 2.3±0.3. Dotted line shows a best-fit Michaelis–Menten curve for comparison. (c) The effect of nucleotides (1 mM) and inhibitors (10 mM NEM, 1 mM orthovanadate (Vi) or 0.2 mM beryllium fluoride (BeFx)) on [3H] ATR transfer from proteoliposomes to liposomes. Percent relative retinal transfer activity data displayed as a mean with error bars representing±s.e.m for n=3. (d) Effect of ATP, ADP and AMP–PNP on [3H] ATR transfer from donor proteoliposomes reconstituted with WT ABCA4 or the ATPase-impaired K969M/K1978M double mutant (ABCA4-MM) purified from transfected HEK293 cells. ATR concentration was 10 μM. Data are plotted as a mean with error bars representing±s.e.m for n=3.](https://figures.cochat.ai/paper-figures/ae5c3c3db2d545c9b2b6e855aacbfc31/abca4-is-an-n-retinylidene-phosphatidylethanolamine-and-phosphatidylethanolamine-figure-2.jpg)
![Figure 3 Effect of retinoids and PE on ATP-dependent transfer of ATR from donor proteoliposomes to acceptor liposomes. (a) Inhibition of ATP-dependent [3H] ATR transfer (10 μM) from ABCA4-containing donor proteoliposomes to acceptor liposomes with increasing concentrations of all-trans retinol or N-retinyl-PE. Donor proteoliposomes were reconstituted with ABCA4 purified from bovine ROS membranes. Percent-relative retinal transfer plotted as a mean with error bars representing±s.d. for n=3. (b) ATP-dependent transfer of [3H] ATR from ABCA4-containing proteoliposomes composed of only DOPC (PC) or DOPC containing 30% DOPE (PE). Sigmoidal curve for PE was generated and yielded a K0.5=6.7 μM±0.3 with a Hill coefficient of 2.1±0.2. Percent relative retinal transfer plotted as a mean with error bars representing±s.d. for n=3. (c) Effect of increasing DOPE on the ATP-dependent transfer of [3H] ATR from DOPC/DOPE proteoliposomes reconstituted with either WT ABCA4 or ABCA4-MM mutant. Data was plotted as mean with error bars representing±s.e.m. for n=6. (d) Absorption spectra of purified ABCA4 with bound retinoid substrate. Spectrum at neutral pH (solid line) shows a maximum of 360 nm characteristic of non-protonated N-retinylidene-PE. Treatment with HCl resulted in an absorption maximum of 440 nm characteristic of protonated N-retinylidene-PE. Treatment with NaCNBH3 resulted in a shift to 330 nm characteristic of N-retinyl-PE. (e) HPLC chromatograph of NaCNBH3 reduced retinoid substrate in ABCA4 with y-axis in absorbance units (A.U.). Retention time and absorption spectrum (inset) of the predominant peak (*) showing a λ-max at 330 nm.](https://figures.cochat.ai/paper-figures/8ca525c363d440339c1c2a932e3c1a8b/abca4-is-an-n-retinylidene-phosphatidylethanolamine-and-phosphatidylethanolamine-figure-3.jpg)
![Figure 4 ATP-dependent transfer of ATR from ROS discs to acceptor vesicles. (a) Coomassie blue stained SDS gel (CB) and western blot (WB) of bovine ROS disc vesicles used in the ATR transfer reactions. (b) Time course for the transfer of [3H] ATR from donor disc vesicles to acceptor vesicles. At 30 min, 5 mM ATP or AMP–PNP (arrow) was added to start the transfer reaction. A higher ATP concentration was required to compensate for the presence of non-specific ATPase in the disc membranes. Data plotted as a mean with error bars representing±s.d. for n=3. (c) ATP-dependent rate of [3H] ATR transfer (retinal transfer activity) from disc vesicles to acceptor liposomes as a function of ATR concentration. The best-fit sigmoidal curve was generated for a K0.5 of 6.8±0.3 μM and a Vmax of 4.9±0.1 nmol min−1 per mg protein, and yielded a Hill coefficient of 1.8±0.1. Data plotted as a mean with error bars representing±s.d. for n=3. (d) Coomassie blue (CB)-stained gels of ROS (left panel) and hypotonically lysed and washed discs (middle panel) from wild-type (Wt) and abca4 knockout (abca4−/−) mice. Western blot (right panel) labelled for ABCA4 and guanylate cyclase 1 (GC1). ROS and disc membranes from WT and abca4−/− mice display similar protein profiles except for the absence of ABCA4 in the abca4−/− preparations as revealed by western blotting. (e) ATP-dependent [3H] ATR transfer from disc membranes of WT and abca4−/− mice to acceptor vesicles. Data plotted as a mean with error bars representing±s.e.m. for n=9.](https://figures.cochat.ai/paper-figures/65e0f06ad74342f69e8a4dac1e45f5db/abca4-is-an-n-retinylidene-phosphatidylethanolamine-and-phosphatidylethanolamine-figure-4.jpg)

![Figure 6 Effect of Walker A and Stargardt mutations on ATR transfer activity. (a) Wild-type and mutant ABCA4 containing a 1D4 epitope were expressed in HEK293T cells and purified on a Rho-1D4 immunoaffinity matrix. Commassie blue stained gel (upper) and western blot (lower) for the various ABCA4 mutants. Lanes labelled I (input) are the HEK293T detergent solubilized extract applied to the immunoaffinity matrix. Lanes labelled E (eluted) are fractions released from the immunoaffinity matrix with the 1D4 peptide. (b) ATP-dependent [3H] ATR transfer activity for the various mutants relative to wild-type ABCA4. Percent-relative retinal transfer plotted as a mean with error bars representing±s.e.m. for n=9 from three independent experiments. Statistically significant differences (P<0.05) are denoted with * for the indicated data sets as determined by analysis of variance (ANOVA). (c) ATPase activity of the Stargardt mutants as a function of ATR concentration and expressed as a % of WT activity in the absence of retinal. Data plotted as a mean with error bars representing ± s.e.m. for n=6 from two independent experiments. (d) ATPase activity of the Walker A mutants as a function of ATR concentration. Data plotted as a mean with error bars representing±s.e.m. for n=6 from two independent experiments. (e) Binding of N-retinylidene-PE to immobilized WT and mutant ABCA4 and release by 0.5 mM ATP. Binding normalized to WT ABCA4. Data plotted as a mean±s.e.m. for n=9 from three independent experiments. (f) ATP-dependent flippase activity of NBD-labelled-PE by mutant ABCA4. Percent-relative PE flipping plotted as a mean with error bars representing±s.e.m. for n=9 from three independent experiments. Statistically significant differences (P<0.05) are denoted with * as determined for the indicated data sets by ANOVA.](https://figures.cochat.ai/paper-figures/ee3dbea7cbbd4658b6070e6be24f81d0/abca4-is-an-n-retinylidene-phosphatidylethanolamine-and-phosphatidylethanolamine-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although numerous lipids stimulate ATP hydrolysis by ABCA4, all-trans-retinal or its phosphatidylethanolamine (PE) conjugate, N-retinylidene-PE (N-ret-PE) are the preferred substrates.524,525”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [525]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The topology of this protein in combination with the logic of the visual cycle suggest that ABCA4 acts as an importer, an assumption recently confirmed experimentally.525”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [525]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
ABC transporters: the power to change
Rees, D. C., Johnson, E., & Lewinson, O. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2646 · Cited by 1,450
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems
Davidson, A. L., Dassa, E., Orelle, C., & Chen, J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-07 · Cited by 1,420
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881
Cited by
Items 101–200 of 282
ATP binding cassette importers in eukaryotic organisms
Choi, C. C., & Ford, R. C. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12702 · Cited by 35
Antigen Translocation Machineries in Adaptive Immunity and Viral Immune Evasion
Mayerhofer, P. U., & Tampé, R. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.006 · Cited by 39
The lysosomal protein ABCD4 can transport vitamin B12 across liposomal membranes in vitro
Kitai, K., Kawaguchi, K., Tomohiro, T., Morita, M., So, T., & Imanaka, T. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100654 · Cited by 37
Gasdermin E mediates photoreceptor damage by all-trans-retinal in the mouse retina
Cai, B., Liao, C., He, D., Chen, J., Han, J., Lu, J., Qin, K., Liang, W., Wu, X., Liu, Z., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101553 · Cited by 36
Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
Villa, M., Wu, J., Hansen, S. M., & Pahnke, J. (2024) · Cells · doi:10.3390/cells13090740 · Cited by 44
Functional Characterization of ABCA4 Missense Variants Linked to Stargardt Macular Degeneration
Garces, F. A., Scortecci, J. F., & Molday, R. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010185 · Cited by 41
Self-citationStrauss, R. W., Muñoz, B. E., Jha, A., Ho, A., Cideciyan, A. V., Kasilian, M. L., Wolfson, Y., Sadda, S. R., West, S. K., Scholl, H. P. N., et al. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.06.003 · Cited by 31
Picky ABCG5/G8 and promiscuous ABCG2 ‐ a tale of fatty diets and drug toxicity
Khunweeraphong, N., Mitchell, J., Szöllősi, D., Hussein, T. O. K., Kuchler, K., Kerr, I. D., Stockner, T., & Lee, J. (2020) · FEBS Letters · doi:10.1002/1873-3468.13938 · Cited by 28
Ng, E. S. Y., Kady, N., Hu, J. G., Dave, A. R., Jiang, Z., Pei, J., Gorin, M. B., Matynia, A., & Radu, R. A. (2022) · Cells · doi:10.3390/cells11213462 · Cited by 28
Photoreceptor Inner and Outer Segments
Baker, S. A., & Kerov, V. (2013) · Current topics in membranes · doi:10.1016/b978-0-12-417027-8.00007-6 · Cited by 43
Liu, Q., Sabirzhanova, I. B., Bergbower, E. A. S., Yanda, M. K., Guggino, W. G., & Cebotaru, L. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000146 · Cited by 25
Cryo-EM structures of the human surfactant lipid transporter ABCA3
Xie, T., Zhang, Z., Yue, J., Fang, Q., & Gong, X. (2022) · Science Advances · doi:10.1126/sciadv.abn3727 · Cited by 26
Structure and mechanism of the bacterial lipid ABC transporter, MlaFEDB
Ekiert, D. C., Coudray, N., & Bhabha, G. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102429 · Cited by 27
Pahnke, J., Bascuñana, P., Brackhan, M., Stefan, K., Namasivayam, V., Koldamova, R. P., Wu, J., Möhle, L., & Stefan, S. M. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3528 · Cited by 36
Tornabene, P., Trapani, I., Centrulo, M., Marrocco, E., Minopoli, R., Lupo, M., Iodice, C., Gesualdo, C., Simonelli, F., Surace, E. M., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.10.004 · Cited by 25
“We showed efficient reconstitution of the large ATP-binding cassette subfamily A member 4 (ABCA4) protein, which encodes the photoreceptor (PR)-specific all-trans-retinal transporter.(12) ABCA4 is critically important for the clearance of photoisomerized all-trans-retinal from the photoreceptor disk lumen.”
BackgroundPark, J. C., Collison, F. T., Fishman, G. A., Allikmets, R. L., Zernant, J., Liu, M., & McAnany, J. J. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16955 · Cited by 25
Vitamin A, systemic T-cells, and the eye: Focus on degenerative retinal disease
Thirunavukarasu, A. J., Ross, A. C., & Gilbert, R. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.914457 · Cited by 31
Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
Gil, J. P., & Fançony, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.759422 · Cited by 23
Mechanisms of Biotin Transport
Polyak, S. W. (2015) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000210 · Cited by 23
Highly Penetrant Alleles in Age-Related Macular Degeneration
den Hollander, A. I., & de Jong, E. K. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017202 · Cited by 23
Kawaguchi, K., Mukai, E., Watanabe, S., Yamashita, A., Morita, M., So, T., & Imanaka, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-81949-3 · Cited by 25
Structure and Function of Multidrug Resistance Protein 1
Yakusheva, E. N., & Титов, Д. С. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918080047 · Cited by 23
Vitamin A aldehyde-taurine adduct and the visual cycle
Kim, H. J., Zhao, J., & Sparrow, J. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005714117 · Cited by 22
Polyunsaturated Lipids in the Light-Exposed and Prooxidant Retinal Environment
Longoni, B., & Demontis, G. C. (2023) · Antioxidants · doi:10.3390/antiox12030617 · Cited by 21
Analysis of retinal sublayer thicknesses and rates of change in ABCA4-associated Stargardt disease
Whitmore, S. S., Fortenbach, C. R., Cheng, J. L., DeLuca, A. P., Critser, D. B., Geary, E. L., Hoffmann, J. M., Stone, E. M., & Han, I. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73645-5 · Cited by 22
Retina and RPE lipid profile changes linked with ABCA4 associated Stargardt's maculopathy
Farnoodian, M., Bose, D., Barone, F., Nelson, L. M., Boyle, M. P., Jun, B., Do, K., Gordon, W. C., Kautzmann, M.-A. I., Perera, R. M., et al. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108482 · Cited by 28
Banerjee, A., Pata, J., Chaptal, V., Boumendjel, A., Falson, P., & Prasad, R. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100992 · Cited by 23
Wei, D., Qu, C., Zhao, N., Li, S., Pu, N., Song, Z., & Tao, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102308 · Cited by 23
Fixation Improvement through Biofeedback Rehabilitation in Stargardt Disease
Scuderi, G., Verboschi, F., Domanico, D., & Spadea, L. (2016) · Case Reports in Medicine · doi:10.1155/2016/4264829 · Cited by 21
Biogenesis and Function of Peroxisomes in Human Disease with a Focus on the ABC Transporter
Imanaka, T. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00723 · Cited by 22
Clinical and genetic analyses reveal novel pathogenic ABCA4 mutations in Stargardt disease families
Lin, B., Cai, X., Zheng, Z., Huang, X., Liu, X., Qu, J., & Jin, Z. (2016) · Scientific Reports · doi:10.1038/srep35414 · Cited by 20
Substrate Specificity and the Direction of Transport in the ABC Transporters ABCD1–3 and ABCD4
Kawaguchi, K., & Imanaka, T. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c21-01021 · Cited by 23
Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes
Wang, T., Yu, T., Liu, Q., Sung, T., & Higuchi, A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102236 · Cited by 22
Retinol dehydrogenases: Membrane-bound enzymes for the visual function
Lhor, M., & Salesse, C. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0082 · Cited by 26
Zhou, Y., Tao, S.-Y., Chen, H., Huang, L., Zhu, X., Li, Y., Wang, Z., Lin, H., Hao, F., Wang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091962 · Cited by 19
Pharmacotherapy for metabolic and cellular stress in degenerative retinal diseases
Kubota, R., Gregory, J. K., Henry, S., & Mata, N. L. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.013 · Cited by 20
Association between genotype and phenotype in families with mutations in the ABCA4 gene.
Kjellström, U. (2014) · PubMed Central · Cited by 19
Retinal degeneration in animal models with a defective visual cycle
Maeda, A., & Palczewski, K. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.01.001 · Cited by 21
Identification of novel pathogenic ABCA4 variants in a Han Chinese family with Stargardt disease
Qin, X., Cao, Y., Xu, H., Guo, Y., Yang, Z., Lu, C., Yuan, L., & Deng, H. (2018) · Bioscience Reports · doi:10.1042/bsr20180872 · Cited by 20
Tsybovsky, Y., & Palczewski, K. (2014) · Protein Expression and Purification · doi:10.1016/j.pep.2014.02.010 · Cited by 19
Rare and common variants in ROM1 and PRPH2 genes trans-modify Stargardt/ABCA4 disease
Zernant, J., Lee, W., Wang, J., Goetz, K., Ullah, E., Nagasaki, T., Su, P.-Y., Fishman, G. A., Tsang, S. H., Tumminia, S. J., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010129 · Cited by 20
Xu, T., Molday, L. L., & Molday, R. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104614 · Cited by 19
Self-citationDawn of ocular gene therapy: implications for molecular diagnosis in retinal disease
Zaneveld, J. E., Wang, F., Wang, X., & Chen, R. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4443-y · Cited by 17
Reduced macular function in ABCA4 carriers.
Kjellström, U. (2015) · PubMed Central · Cited by 17
Zhu, Q., Rui, X., Li, Y., You, Y., Sheng, X., & Lei, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634843 · Cited by 18
Clinical features and molecular genetics of patients with ABCA4‐retinal dystrophies
Holtan, J. P., Aukrust, I., Jansson, R. W., Berland, S., Bruland, O., Gjerde, B. L., Stokowy, T., Bojović, O., Forsaa, V. A., Austeng, D., et al. (2020) · Acta Ophthalmologica · doi:10.1111/aos.14679 · Cited by 17
Updates on Emerging Interventions for Autosomal Recessive ABCA4-Associated Stargardt Disease
Wang, L., Shah, S. M., Mangwani‐Mordani, S., & Gregori, N. Z. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196229 · Cited by 23
Predominance of hyperopia in autosomal dominant Best vitelliform macular dystrophy
Coussa, R. G., Binkley, E. M., Wilkinson, M. E., Andorf, J. L., Tucker, B. A., Mullins, R. F., Sohn, E. H., Yannuzzi, L. A., Stone, E. M., & Han, I. C. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-317763 · Cited by 16
Recent advances in the dark adaptation investigations.
Yang, G., Chen, T., Tao, Y., & Zhang, Z. (2015) · Europe PMC (PubMed Central) · doi:10.3980/j.issn.2222-3959.2015.06.31 · Cited by 20
Żuberek, M., Stępkowski, T. M., Kruszewski, M. K., & Grzelak, A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.02.004 · Cited by 17
Sun, D., Schur, R. M., Sears, A. E., Gao, S., Sun, W., Naderi, A., Kern, T. S., Palczewski, K., & Lu, Z. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00130 · Cited by 17
Advances and therapeutic opportunities in visual cycle modulation
Zaluski, J., Bassetto, M., Kiser, P. D., & Tochtrop, G. P. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101360 · Cited by 15
Burnight, E. R., Fenner, B. J., Han, I. C., DeLuca, A. P., Whitmore, S. S., Bohrer, L. R., Andorf, J. L., Sohn, E. H., Mullins, R. F., Tucker, B. A., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad176 · Cited by 15
A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease
Fenner, B. J., Whitmore, S. S., DeLuca, A. P., Andorf, J., Daggett, H. T., Luse, M. A., Haefeli, L. D. M., Riley, J. B., Critser, D. B., Wilkinson, M. E., et al. (2024) · Ophthalmology · doi:10.1016/j.ophtha.2024.01.035 · Cited by 15
Clinical and genetic characteristics of Stargardt disease in a large Western China cohort: Report 1
Liu, X., Meng, X., Yang, L., Long, Y., Fujinami‐Yokokawa, Y., Ren, J., Kurihara, T., Tsubota, K., Tsunoda, K., Fujinami, K., et al. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31838 · Cited by 15
Gene Therapy for Inherited Retinal Disorders: Update on Clinical Trials
Michalakis, S., Gerhardt, M. J., Rudolph, G., Priglinger, S. G., & Priglinger, C. (2021) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-1384-0818 · Cited by 19
Gaeta, A. L., Nourse, J. B., Willicott, K., McKay, L. E., Keogh, C. M., Peter, K., Russell, S. N., Hamamichi, S., Berkowitz, L. A., Caldwell, K. A., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010115 · Cited by 17
Novel variants associated with Stargardt disease in Chinese patients
Hu, F., Gao, F., Li, J., Xu, P., Wang, D., Chen, F., Zhang, S., & Wu, J. (2020) · Gene · doi:10.1016/j.gene.2020.144890 · Cited by 16
Morra, G., Razavi, A. M., Menon, A. K., & Khelashvili, G. (2022) · Structure · doi:10.1016/j.str.2022.05.010 · Cited by 14
Full-field ERG as a predictor of the natural course of ABCA4-associated retinal degenerations.
Schroeder, M. S., & Kjellström, U. (2018) · PubMed Central · Cited by 14
Huang, D., Thompson, J. A., Charng, J., Chelva, E. S., McLenachan, S., Chen, S., Zhang, D., McLaren, T. L., Lamey, T. M., Constable, I. J., et al. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1259 · Cited by 13
Cheng, X., He, D., Liao, C., Lin, S., Tang, L., Wang, Y., Hu, J., Li, W. S., Liu, Z., Wu, Y., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30103 · Cited by 17
Zhang, R., Wang, L., Wang, Y.-F., Wu, C., Lei, C.-L., Wang, M., & Ma, L. (2015) · Gene · doi:10.1016/j.gene.2015.04.068 · Cited by 14
Stargardt’s Disease: Molecular Pathogenesis and Current Therapeutic Landscape
Dayma, K., Rajanala, K., & Upadhyay, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26147006 · Cited by 15
Katzeff, J. S., Lok, H. C., Bhatia, S., Fu, Y., Halliday, G. M., & Kim, W. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1043127 · Cited by 15
Intercellular transfer of multidrug resistance mediated by extracellular vesicles
Yang, A., Sun, H., & Wang, X. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.84 · Cited by 18
Lunegova, D. A., Александрович, Г. Д., Senin, I. I., Gudkova, V. R., Sidorenko, S. V., Tiulina, V. V., Shebardina, N. G., Yakovleva, M. A., Feldman, T. B., Ramonova, A. A., et al. (2024) · FEBS Journal · doi:10.1111/febs.17335 · Cited by 16
Structural insights into human ABCA7-mediated lipid transport
Fang, S., Wang, L., Cheng, M., Xu, D., Chen, Z., Wang, J., Liao, W., Li, Y., Zhou, C., Hou, W., et al. (2025) · Structure · doi:10.1016/j.str.2024.12.015 · Cited by 14
Pandey, R. S., Krebs, M. P., Bolisetty, M. T., Charette, J. R., Naggert, J. Κ., Robson, P., Nishina, P. M., & Carter, G. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810419 · Cited by 12
Stem Cells as Tools for Studying the Genetics of Inherited Retinal Degenerations
Wiley, L. A., Burnight, E. R., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017160 · Cited by 17
Watson, A., Queen, R. A., Ferrández-Peral, L., Dorgau, B., Collin, J., Nelson, A., Hussain, R., Coxhead, J., McCorkindale, M., Atkinson, R., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07420-7 · Cited by 14
Green, J. S., O’Rielly, D. D., Pater, J. A., Houston, J., Rajabi, H., Galutira, D., Benteau, T., Sheaves, A., Abdelfatah, N., Bautista, D., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0581-4 · Cited by 15
Plastic structures for diverse substrates: A revisit of human ABC transporters
Hou, W., Xu, D., Wang, L., Chen, Y., Chen, Z., Zhou, C., & Chen, Y. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26406 · Cited by 13
Cell-cell interaction in the pathogenesis of inherited retinal diseases
Du, X., Butler, A. G., & Chen, H. Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1332944 · Cited by 12
Chen, X., Wang, B., Sarkar, A., Huang, Z., Ruiz, N. V., Yeung, A. T., Chen, R., & Han, C. (2025) · Science Advances · doi:10.1126/sciadv.adr5448 · Cited by 14
Clinical applications of retinal gene therapies
Fu, X., Huu, V. A. N., Duan, Y., Kermany, D., Valentim, C. C. S., Zhang, R., Zhu, J., Zhang, C. L., Sun, X., & Zhang, K. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby004 · Cited by 13
Al-Shumary, D. S., Al-Shammari, A. M., & Rasheed, M. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.11.3969 · Cited by 14
Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing
Kaltak, M., Corradi, Z., Collin, R. W. J., Swildens, J., & Cremers, F. P. M. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad129 · Cited by 11
Stargardt disease-associated in-frame ABCA4 exon 17 skipping results in significant ABCA4 function
Kaltak, M., Blanco-Garavito, R., Molday, L. L., Dhaenens, C., Souied, E. H., Platenburg, G. J., Swildens, J., Molday, R. S., & Cremers, F. P. M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04406-x · Cited by 11
Self-citationABCC Transporter Gene MoABC-R1 Is Associated with Pyraclostrobin Tolerance in Magnaporthe oryzae
Hu, P., Liu, Y., Zhu, X., & Kang, H. (2023) · Journal of Fungi · doi:10.3390/jof9090917 · Cited by 10
Losing, preserving, and restoring vision from neurodegeneration in the eye
Kerschensteiner, D. (2023) · Current Biology · doi:10.1016/j.cub.2023.08.044 · Cited by 12
Kjellström, U., Veiga‐Crespo, P., Andréasson, S., & Ekström, P. A. R. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19861 · Cited by 10
Genotypic profile and phenotype correlations of ABCA4-associated retinopathy in Koreans.
Joo, K., Seong, M., Park, K. H., Park, S. S., & Woo, S. J. (2019) · PubMed Central · Cited by 10
Piotter, E., McClements, M. E., & MacLaren, R. E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.814131 · Cited by 12
Adler, L., Chen, C., & Koutalos, Y. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.02.007 · Cited by 10
Nagampalli, R. S. K., Vadla, G. P., & Nadendla, E. K. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5010006 · Cited by 16
Functional characterization of ABCA4 genetic variants related to Stargardt disease
Kim, B. M., Song, H. S., Kim, J., Kwon, E. Y., Ha, S. Y., Kim, M., & Choi, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-26912-6 · Cited by 8
Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis
Ng, E. S. Y., Hu, J. G., Jiang, Z., & Radu, R. A. (2024) · The FASEB Journal · doi:10.1096/fj.202400210rr · Cited by 9
Yang, B., Yang, K., Xi, R., Chen, J., & Wu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413624 · Cited by 9
Characterising Splicing Defects of ABCA4 Variants within Exons 13-50 in Patient-Derived Fibroblasts
Huang, D., Thompson, J. A., Chen, S., Adams, A. M., Pitout, I. L., Lima, A., Zhang, D., Jeffery, R. C. H., Attia, M. S., McLaren, T. L., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109276 · Cited by 10
Muller, A., Sullivan, J., Schwarzer, W., Wang, M., Park‐Windhol, C., Klingler, B., Matsell, J., Hostettler, S. M., Galliker, P., Duman, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.535579 · Cited by 11
Parchure, A. S., & Peng, Y. B. (2020) · The Open Pain Journal · doi:10.2174/1876386302013010007 · Cited by 11
Lakli, M., Onnée, M., Carrez, T., Becq, F., Falguières, T., & Fanen, P. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116468 · Cited by 11
Retinoid dynamics in vision: from visual cycle biology to retina disease treatments
Swigris, J., Widjaja‐Adhi, M. A. K., & Golczak, M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108902 · Cited by 8
Simultaneous Expression of ABCA4 and GPR143 Mutations: A Complex Phenotypic Manifestation
Lee, W., Schuerch, K., Xie, Y., Zernant, J., Tsang, S. H., Sparrow, J. R., & Allikmets, R. L. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19621 · Cited by 8
Flip-Flop Promotion Mechanisms by Model Transmembrane Peptides
Nakao, H., & Nakano, M. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00133 · Cited by 8
Suárez-Herrera, N., Li, C. H. Z., Leijsten, N., Karjosukarso, D. W., Corradi, Z., Bukkems, F., Duijkers, L., Cremers, F. P. M., Hoyng, C. B., Garanto, A., et al. (2024) · Cells · doi:10.3390/cells13070601 · Cited by 7
Introduction: Overview of the Human Eye, Mammalian Retina, and the Retinoid Visual Cycle
Cioffi, C. L. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_94 · Cited by 14
Al‐Khuzaei, S., Shah, M., Foster, C. R., Yu, J., Broadgate, S., Halford, S., & Downes, S. M. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211056384 · Cited by 10
STARGARDT DISEASE: Beyond Flecks and Atrophy
Light, J. G., Fard, M. A., Yaseri, M., Aiyetan, P., Handa, J. T., & Ebrahimi, K. B. (2017) · Retina · doi:10.1097/iae.0000000000001484 · Cited by 8
Metadata
- Authors
- Quazi, F., Lenevich, S., & Molday, R. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Molday, Robert S.
- Venue
- Nature Communications
- Published
- 2012-06-26
- Volume
- 3
- Issue
- 1
- Pages
- 925-925
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3871175
- OpenAlex
- W1997517812
- Cited by
- 276
- References
- 65
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 27 · 2023: 23 · 2022: 25 · 2021: 26 · 2020: 30 · 2019: 14 · 2018: 11 · 2017: 15 · 2016: 13 · 2015: 20 · 2014: 25 · 2013: 12 · 2012: 3
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research (92101_1, CIHR RMF-92101)
- Natural Sciences and Engineering Research Council of Canada
- National Eye Institute (EY002422, R01EY002422)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- ABCA4, ABC transporters, phosphatidylethanolamine, photoreceptors, retinoid transport
- MeSH terms
- Animals, Liposomes, Phosphatidylethanolamines, Retinoids, Mice, Knockout, ATP-Binding Cassette Transporters, Photoreceptor Cells, Vertebrate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.